18 June 2013
Keywords: merck/s-p, vytorin, lowers, ldl, cholesterol, astrazeneca, crestor
Article | 26 June 2006
US drug majors Merck & Co and Schering-Plough presented results from a new clinical study at the International Symposium on Atherosclerosis
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 June 2006
10 July 2006
12 June 2006
© 2013 thepharmaletter.com